Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...
Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...
Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead ...
Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead increase the risk of chronic liver damage and cancer as we age.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback